Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension

Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension

Purpose: To study and compare the efficacy and safety profile of Rho-kinase inhibitor (netarsudil 0.02%) and prostaglandin analog (bimatoprost 0.01%) both as monotherapy and in combination. Design: Prospective, randomized, monocentric, open-label clinical trial. Methods: Patients ≥20 years of age wi...

Full description

Bibliographic Details
Main Authors: Saima Shahid, Syed Wajahat A Rizvi, Adeeb A Khan, Humayoun Ashraf, Afeefa Akhter
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Indian Journal of Ophthalmology
Subjects:
bimatoprost
conjunctival hyperemia
efficacy
netarsudil
safety
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2024;volume=72;issue=3;spage=427;epage=431;aulast=Shahid

Similar Items

Similar Items